{"TopicDetails": {"type": 0, "ccm2Id": 31077469, "cftId": 0, "identifier": "IMI2-2016-09-06", "title": "JOINT INFLUENZA VACCINE EFFECTIVENESS STUDIES", "publicationDateLong": 1461715200000, "callIdentifier": "H2020-JTI-IMI2-2016-09-two-stage", "callTitle": "H2020-JTI-IMI2-2016-09-two-stage", "callccm2Id": 31077473, "allowPartnerSearch": true, "workProgrammepart": {"id": 3051, "ccm_id": 31078048, "wp_part": "H2020-JTI-IMI-2016", "wp_year": "H2020-JTI-IMI-2016", "wp_title": "IMI2 Work Plan 2016", "wp_website": "http://www.imi.europa.eu/", "wp_document": "http://ec.europa.eu/research/participants/data/ref/h2020/other/wp/jtis/h2020-wp16-imi_en.pdf"}, "frameworkProgramme": {"id": 31045243, "abbreviation": "H2020", "description": "Horizon 2020 Framework Programme"}, "programmeDivision": [{"id": 31047894, "abbreviation": "EU.3.1.", "description": "Health, demographic change and wellbeing"}, {"id": 31047893, "abbreviation": "EU.3.", "description": "Societal Challenges"}, {"id": 31062059, "abbreviation": "EU.3.1.7.", "description": "Innovative Medicines Initiative 2 (IMI2)"}, {"id": 31045244, "abbreviation": "EC", "description": "EC Treaty"}, {"id": 31062071, "abbreviation": "EU.3.1.7.12.", "description": "Vaccine"}], "topicMGAs": [], "tags": ["registries", "surveillance", "vaccines", "immunology", "Ebola"], "keywords": ["Registries", "Surveillance", "Vaccines"], "flags": ["IntlCoop"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "IMI2-RIA Research and Innovation action", "typeOfMGA": []}], "plannedOpeningDate": "27 April 2016", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["26 July 2016", "10 January 2017"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3202715": [{"action": "IMI2-2016-09-03 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "27 April 2016", "deadlineModel": "two-stage", "deadlineDates": ["26 July 2016", "10 January 2017"], "budgetYearMap": {"2016": 117656000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2016-09-02 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "27 April 2016", "deadlineModel": "two-stage", "deadlineDates": ["26 July 2016", "10 January 2017"], "budgetYearMap": {"2016": 117656000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2016-09-01 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "27 April 2016", "deadlineModel": "two-stage", "deadlineDates": ["26 July 2016", "10 January 2017"], "budgetYearMap": {"2016": 117656000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2016-09-04 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "27 April 2016", "deadlineModel": "two-stage", "deadlineDates": ["26 July 2016", "10 January 2017"], "budgetYearMap": {"2016": 117656000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2016-09-06 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "27 April 2016", "deadlineModel": "two-stage", "deadlineDates": ["26 July 2016", "10 January 2017"], "budgetYearMap": {"2016": 117656000}, "budgetTopicActionMap": {}}, {"action": "IMI2-2016-09-05 - IMI2-RIA Research and Innovation action", "plannedOpeningDate": "27 April 2016", "deadlineModel": "two-stage", "deadlineDates": ["26 July 2016", "10 January 2017"], "budgetYearMap": {"2016": 117656000}, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2016"]}, "description": "<SPAN class=\"topicdescriptionkind\">Specific Challenge</SPAN>:<p>A strengthened capacity in Europe to monitor the effectiveness of the yearly seasonal influenza vaccines across age, risk groups and vaccines is needed. National public health bodies have a role in assessing national vaccination programmes, and vaccine manufacturers are accountable for the quality and integrity of vaccine product-specific data presented to regulatory authorities. Collaboration and partnership amongst public health institutes, regulatory bodies and vaccine manufacturers is therefore necessary to build a strong platform to perform influenza effectiveness assessments</p>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p>The scope of the action includes the development and validation of a sustainable governance model for the evaluation of type/brand-specific seasonal influenza vaccine effectiveness in Europe, through collaboration between public and private partners. Furthermore, the scope of the action is to build an EU/EEA-wide recognised and accepted platform for influenza vaccine effectiveness studies, including the development of tools for communication and dissemination of the results obtained from the studies.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p>It is expected that the action will result in better information for healthcare professionals and the general public about the performance of the influenza vaccines in use, better information on the performance of national immunization programmes, improved understanding of the benefits of influenza vaccination, and better understanding of the factors that impact influenza vaccine effectiveness. The action will likely positively influence societal acceptance of influenza vaccines, result in improved vaccine coverage in the EU and ultimately reduced disease burden.</p><p>If successful, the model could be expanded to evaluation of all other vaccines used in national/sub-national immunisation programmes. </p>\n<SPAN class=\"topicdescriptionkind\">Cross-cutting Priorities</SPAN>:<p><a href=\"//ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-search;statusCodes=31094501,31094502,31094503;programCcm2Id=31045243;crossCuttingPriorityCode=IntlCoop;sortQuery=sortStatus;orderBy=asc\">International cooperation</a><br></p>\n", "conditions": "<p>Please read carefully all provisions below before the preparation of your application !</p>\r\n<p>You can access the description of the&nbsp;different topics in the <a target=\"_blank\" href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche16-9-imi2-ju_en.pdf\">IMI2&nbsp;Call 9 topics text&nbsp;</a></p>\r\n<p>The budget breakdown for this Call is given at the end&nbsp;of the Call topics text, in the <a target=\"_blank\" href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_fiches/jtis/h2020-call-fiche16-9-imi2-ju_en.pdf\">Call Conditions </a>section (starting page 61), as well as the following information :</p>\r\n<ol>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">List of countries and applicable rules for funding</span></strong><br />\r\n    &nbsp;</li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Eligibility and admissibility conditions<br />\r\n    </span></strong></li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Evaluation criteria and procedure, scoring and threshold:</span></strong> described in&nbsp;the <a target=\"_blank\" href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-pse-imi-ju-v1.3_en.pdf\">Manual for submission, evaluation and grant award</a>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <br />\r\n    &nbsp;</li>\r\n    <li><span style=\"color: rgb(0,51,102)\"><strong>Indicative timetable for evaluation and grant agreement<br />\r\n    </strong></span></li>\r\n    <li><strong><span style=\"color: rgb(0,51,102)\">Provisions, proposal templates and evaluation forms for the type of action under this topic:</span></strong> <br />\r\n    <br />\r\n    <strong><u>IMI2 Research and Innovation Action (IMI2-RIA) and (IMI2-IA):</u><br />\r\n    </strong><br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/guides_for_applicants/jtis/h2020-guide-rel-prov-imi-ju_en.pdf\">Summary of the most relevant provisions for participating in IMI2 actions</a><br />\r\n    <a target=\"_blank\" href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/call_ptef/ef/h2020-call-ef-imi2-ria-ia-2016_en.pdf\">Standard evaluation form</a><br />\r\n    Proposal templates are available after entering the submission tool SOFIA.<br />\r\n    <a href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/mga/jtis/h2020-mga-imi_en.pdf\">IMI2 Model Grant Agreement</a><br />\r\n    <a target=\"_blank\" href=\"http://ec.europa.eu/research/participants/data/ref/h2020/other/legal/templ/h2020_tmpl-clinical-studies-imi-ju_en.pdf\">Template for Essential Clinical Trials Information</a><br />\r\n    <br />\r\n    <br />\r\n    &nbsp;</li>\r\n</ol>", "supportInfo": "<p><strong><a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/index_en.htm\">H2020 Online Manual</a></strong> your online guide on the procedures from proposal submission to managing your grant.<br />\r\n<br />\r\n&nbsp;</p>\r\n<p><strong><span>Contact the IMI&nbsp;JU&nbsp;Programme Office : <a href=\"mailto:Infodesk@imi.europa.eu\">Infodesk@imi.europa.eu</a> Tel : 0032 (2) 221 81 81</span></strong></p>\r\n<p><strong><span>Contact the IMI&nbsp;SOFIA&nbsp;Helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc. : <a href=\"mailto:sofia@imi.europa.eu\">sofia@imi.europa.eu</a> </span></strong></p>\r\n<p><strong><span><a href=\"http://ec.europa.eu/research/participants/portal/desktop/en/support/faq.html\">Participant Portal FAQ</a> </span></strong><span>&ndash; Submission of proposals.</span><br />\r\n<strong><br />\r\n<span><a href=\"http://ec.europa.eu/research/participants/portal4/desktop/en/support/national_contact_points.html\">National Contact Points (NCP)</a>&nbsp;-&nbsp;</span></strong><span>contact your NCP for further assistance.</span><br />\r\n<strong><br />\r\n<span><a href=\"http://ec.europa.eu/research/index.cfm?lg=en&amp;pg=enquiries\">Research Enquiry Service</a></span></strong><span> &ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span><br />\r\n<a href=\"http://een.ec.europa.eu/\"><br />\r\n<strong>Enterprise Europe Network</strong></a> &ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.</p>\r\n<p>Contact the EIT for further assistance related to the call, topics and the content of proposals via the <strong><a href=\"http://eit.europa.eu/interact/contact-us\">Contact Page on the EIT website</a></strong>.<br />\r\n<a href=\"http://www.imi.europa.eu/content/states-representatives-groups\"><br />\r\n<strong>IMI States Representative Group (SRG)</strong></a> &ndash; contact you SRG member for assistance.<br />\r\n<strong><br />\r\nEthics</strong> &ndash; for compliance with ethical issues, see the<a href=\"http://ec.europa.eu/research/participants/docs/h2020-funding-guide/cross-cutting-issues/ethics_en.htm\"> Participant Portal</a>&nbsp;and&nbsp;<a href=\"http://ec.europa.eu/research/swafs/index.cfm?pg=policy&amp;lib=ethics\">Science and Society Portal</a><br />\r\n<a href=\"http://www.iprhelpdesk.eu/\"><br />\r\n<strong>European IPR Helpdesk</strong></a> assists you on intellectual property issues<br />\r\n<a href=\"http://www.cen.eu/cen/Services/Innovation/Pages/default.aspx\"><br />\r\n<strong>CEN</strong></a> and <a href=\"http://www.cenelec.eu/aboutcenelec/whatwestandfor/fosterinnovation/randd.html\"><strong>CENELEC</strong></a>, the European Standards Organisations, advise you how to tackle standardisation in your project proposal. Contact CEN-CENELEC Research Helpdesk at <a href=\"mailto:research@cencenelec.eu\">research@cencenelec.eu</a>.<br />\r\n<a href=\"http://ec.europa.eu/euraxess/pdf/brochure_rights/am509774CEE_EN_E4.pdf\"><br />\r\n<strong>The European Charter for Researchers and the Code of Conduct for their recruitment</strong></a><br />\r\n<a href=\"http://www.imi.europa.eu/content/partner-search\"><br />\r\n<strong>IMI Partner Search Tool</strong></a> helps you find a partner organisation for your proposal</p>", "sepTemplate": "<p>The submission system is planned to be opened on the date stated on the topic header.</p>", "links": [{"callIdentifier": "H2020-JTI-IMI2-2016-09-two-stage", "status": "Closed", "criterionType": "SubFundingScheme", "criterionTypeDescription": "subfunding schemes", "criterionCode": "IMI2-RIA", "criterionDescription": "Research and Innovation action", "url": "https://sofia.imi.europa.eu/Pages/Default.aspx", "startDate": "Apr 26, 2016 5:00:00 PM"}], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"latestInfos": [{"approvalDate": "Apr 27, 2016 6:30:00 PM", "lastChangeDate": "Apr 27, 2016 6:30:00 PM", "content": "The submission session is now available for: IMI2-2016-09-01(IMI2-RIA), IMI2-2016-09-03(IMI2-RIA), IMI2-2016-09-02(IMI2-RIA), IMI2-2016-09-04(IMI2-RIA), IMI2-2016-09-06(IMI2-RIA), IMI2-2016-09-05(IMI2-RIA)"}, {"approvalDate": "Apr 27, 2016 5:56:45 PM", "lastChangeDate": "Apr 27, 2016 5:56:45 PM", "content": "The submission session is now available for: IMI2-2016-09-01(IMI2-RIA), IMI2-2016-09-03(IMI2-RIA), IMI2-2016-09-02(IMI2-RIA), IMI2-2016-09-04(IMI2-RIA), IMI2-2016-09-06(IMI2-RIA), IMI2-2016-09-05(IMI2-RIA)"}, {"approvalDate": "Apr 27, 2016 5:40:50 PM", "lastChangeDate": "Apr 27, 2016 5:40:50 PM", "content": "The submission session is now available for: IMI2-2016-09-01(IMI2-RIA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}